Leia Sensory Prosthesis for Peripheral Neuropathy

(MYN-L001-002 Trial)

Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Mynerva Inc.
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This is a US-specific pilot study to evaluate the short- and long-term effects of the investigational MYNERVA Leia Sensory Prosthesis on gait, neuropathic symptoms and quality of life in US adults with peripheral neuropathy, and to capture insights on the device's usability and perceived clinical effects.

Are You a Good Fit for This Trial?

This trial is for adults in the U.S. who have peripheral neuropathy (nerve damage causing numbness, tingling, or weakness). Participants should be able to walk and use a wearable device. People with conditions that could interfere with using the device may not be eligible.

Inclusion Criteria

Signed informed consent prior to any study procedure
Willingness and ability to attend the initial in-person session (up to 2 hours) and follow-up calls
I am 18 years old or older.
See 4 more

Exclusion Criteria

Implanted electrical devices or pacemakers
Usage of other medical devices for relief of neuropathic symptoms during the study
Inability to perceive the stimulation as tested during calibration
See 9 more

What Are the Treatments Tested in This Trial?

Interventions

  • MYNERVA Leia Sensory Prosthesis

Trial Overview

The study is testing the MYNERVA Leia Sensory Prosthesis, a new wearable device designed to help people with nerve damage improve walking and reduce symptoms. Researchers will look at both short- and long-term effects as well as user experience.

How Is the Trial Designed?

1

Treatment groups

Experimental Treatment

Group I: Leia Sensory ProsthesisExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Mynerva Inc.

Lead Sponsor